Yufeng Li

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. pmc A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology
    Ryan E Campbell-Anson
    Department of Melanoma Medical Oncology, University of Texas, M, d, Anderson Cancer Center, Houston, TX, 77030, USA
    J Immune Based Ther Vaccines 6:1. 2008
  2. pmc Summary of the primer on tumor immunology and the biological therapy of cancer
    Yufeng Li
    Department of Melanoma Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX, USA
    J Transl Med 7:11. 2009
  3. doi request reprint TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy
    Shujuan Liu
    Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    J Immunother 33:371-81. 2010
  4. pmc Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype
    Richard C Wu
    Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
    Clin Cancer Res 18:2465-77. 2012
  5. pmc Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells
    Natalia Martin-Orozco
    Department of Immunology, The University of Texas, M D Anderson Cancer Center, Houston, Texas, USA
    Cancer Res 70:9581-90. 2010
  6. pmc Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function
    Jessica Ann Hernandez-Chacon
    Department of Melanoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Immunother 34:236-50. 2011
  7. doi request reprint Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs
    Dan Li
    Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Immunother 33:975-82. 2010
  8. doi request reprint A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403-455)
    Yufeng Li
    Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Cancer Immunol Immunother 60:515-24. 2011
  9. pmc Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma
    Jahan S Khalili
    Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Clin Cancer Res 18:5329-40. 2012
  10. pmc Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals
    Chantale Bernatchez
    Department of Melanoma Medical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX, United States
    Vaccine 29:3021-30. 2011

Collaborators

Detail Information

Publications13

  1. pmc A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology
    Ryan E Campbell-Anson
    Department of Melanoma Medical Oncology, University of Texas, M, d, Anderson Cancer Center, Houston, TX, 77030, USA
    J Immune Based Ther Vaccines 6:1. 2008
    ..We have tested this technology using 850 cm2 roller bottles compared to conventional T-175 flat-bottom static culture flasks...
  2. pmc Summary of the primer on tumor immunology and the biological therapy of cancer
    Yufeng Li
    Department of Melanoma Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX, USA
    J Transl Med 7:11. 2009
    ..We summarized the topics in this primer for public education. The related topic slides and schedule can be accessed online http://www.isbtc.org/meetings/am08/primer08...
  3. doi request reprint TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy
    Shujuan Liu
    Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA
    J Immunother 33:371-81. 2010
    ..Our results suggest that TGF-beta1-expanded TIL have attributes that might predict efficacy superior to that of conventional TIL...
  4. pmc Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype
    Richard C Wu
    Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA
    Clin Cancer Res 18:2465-77. 2012
    ....
  5. pmc Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells
    Natalia Martin-Orozco
    Department of Immunology, The University of Texas, M D Anderson Cancer Center, Houston, Texas, USA
    Cancer Res 70:9581-90. 2010
    ..Thus, ICOS-L expression by melanoma tumor cells may directly drive Treg activation and expansion in the tumor microenvironment as another mechanism of immune evasion...
  6. pmc Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function
    Jessica Ann Hernandez-Chacon
    Department of Melanoma Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Immunother 34:236-50. 2011
    ..Our results indicate that 4-1BB costimulation may significantly improve TIL survival during melanoma ACT and boost antitumor cytolytic activity...
  7. doi request reprint Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs
    Dan Li
    Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Immunother 33:975-82. 2010
    ....
  8. doi request reprint A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403-455)
    Yufeng Li
    Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Cancer Immunol Immunother 60:515-24. 2011
    ..Experimental verification of our findings is needed to create synthetic adjuvant for vaccines. Such synthetic PGN can direct both adjuvant and cancer antigen to TLR-2...
  9. pmc Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma
    Jahan S Khalili
    Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Clin Cancer Res 18:5329-40. 2012
    ....
  10. pmc Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals
    Chantale Bernatchez
    Department of Melanoma Medical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, TX, United States
    Vaccine 29:3021-30. 2011
    ..Thus, vaccinating with both the 10-mer and 9-mer peptides would be required to immunize a maximum number of individuals in the HLA-A0201(+) population and could lead to more consistent T-cell responses against this region of Survivin...
  11. doi request reprint MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro
    Yufeng Li
    Department of Melanoma Medical Oncology, Graduate School of Biomedical Sciences, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Immunol 184:452-65. 2010
    ..A REP protocol using IL-15 and IL-21 may greatly increase the number of CD28(+) TILs capable of long-term persistence...
  12. ncbi request reprint Short GC-rich RNA similar to miR 1909 and 1915 folds in silico with the 5'-UTR and ORF of Notch and responders: potential for the elimination of cancer stem cells
    Yufeng Li
    Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Oncol Rep 24:1443-53. 2010
    ..Anti-HHB is the first candidate eRNA to fold, in silico, with multiple targets in 5'-UTR and ORF of Notch-1 partners with at least 2-times higher ΔG than natural miRs with 3'-UTR Notch-1...
  13. pmc Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells
    Takashi Mine
    Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Oncol Rep 23:1537-43. 2010
    ..Targeting Notch-1 through its enhancer Gl-1, should be significant for novel treatments to eliminate taxol-resistant cancer stem cells (CSC). i.Gli-1 RNA should be more effective if used together with Taxol...